Coloplast AS (OTCPK:CLPBF)
$ 132.475 0 (0%) Market Cap: 29.20 Bil Enterprise Value: 32.33 Bil PE Ratio: 40.31 PB Ratio: 11.67 GF Score: 94/100

Coloplast A/S Announces Agreement to Acquire Kerecis Call Transcript

Jul 07, 2023 / 09:00AM GMT
Release Date Price: $120 (-4.21%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Coloplast conference call on the acquisition of Kerecis. Throughout today's recorded presentation, all participants will be in a listen-only mode. The presentation will be followed by a question-and-answer session. (Operator Instructions)

I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you very much, operator. Good morning, everybody. Thank you for joining us at a short notice to discuss our agreement to acquire Kerecis for up to USD 1.3 billion or up to around DKK 9 billion. I'm Kristian Villumsen, the CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard and our Investor Relations team. We'll start with a short presentation and then open up for questions.

Please turn to Slide #3. Today, I'm very excited to announce that we've signed an agreement to acquire Kerecis, an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot